Format

Send to

Choose Destination
Int J Clin Exp Pathol. 2011 Apr;4(4):378-84. Epub 2011 Apr 25.

Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.

Author information

1
Laboratory of Research Resources, Research Institute for Longevity Sciences, National Center for Geriatrics and Gerontology Aichi, Japan.

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is caused by the expansion of polyglutamine (polyQ) in atrophin-1 (ATN1), also known as DRPLA protein. ATN1 is ubiquitously expressed in the central nervous system (CNS), although selective regions of CNS are degenerated in DRPLA, and this selective neuronal damage gives rise to the specific clinical features of DRPLA. Accumulation of mutant ATN1 that carries an expanded polyQ tract seems to be the primary cause of DRPLA neurodegeneration, but it is still unclear how the accumulation of ATN1 leads to neu-rodegeneration. Recently, cleaved fragments of ATN1 were shown to accumulate in the disease models and the brain tissues of patients with DRPLA. Furthermore, proteolytic processing of ATN1 may regulate the intracellular localization of ATN1 and its fragments. Therefore, proteolytic processing of ATN1 may provide clues to disease pathogenesis and hopefully aid in the determination of molecular targets for effective therapeutic approaches for DRPLA.

KEYWORDS:

Dentatorubral-pallidoluysian atrophy (DRPLA); atrophin-1 (ATN1); neurodegeneration; polyglutamine (polyQ) disease

PMID:
21577324
PMCID:
PMC3093063
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center